---

---

publishing date : 2021 - 09 - 30    tags : Cancer   

save search

---

Repare Therapeutics to Present Initial Data from the Phase 1/2 TRESR RP-3500 Clinical Trial at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 00:00) - biospace.com/
RPTX 4 | $3.09 2.32% 77K |

Health Technology

| -88.25% | O: 0.89% H: 4.97% C: 1.16%
phase 1 molecular cancer trial conference

---

IMV’s DPX Delivery Technology to be Showcased in Two e-Posters at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 00:00) - biospace.com/
IMV | $0.8225 -2.74% 45K |

Health Technology

| -51.04% | O: -0.6% H: 0.6% C: -0.6%
molecular cancer technology liver conference

---

Bicycle Therapeutics to Present BT5528 Interim Phase I Data at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 00:00) - biospace.com/
BCYC | $24.335 -0.63% 54K |

Health Technology

| -43.87% | O: 0.87% H: 7.94% C: 5.53%
molecular cancer conference

---

Aileron Therapeutics Announces Presentation of New Preclinical Data at Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021
Published: 2021-09-30 (Crawled : 23:00) - globenewswire.com
ALRN | $4.96 -0.8% 46K |

Health Technology

| 424.51% | O: 0.98% H: 4.85% C: 2.91%
presentation molecular cancer conference preclinical pre-clinical

---

Monte Rosa Therapeutics to Present Late-breaking Preclinical Data on Targeting GSPT1 for Myc-driven Cancers at AACR-NCI-EORTC Virtual International Conference
Published: 2021-09-30 (Crawled : 23:00) - globenewswire.com
GLUE | $5.88 -0.68% 29K |

Professional, Scientific, and T...

| -73.97% | O: 0.31% H: 4.32% C: -10.2%
rosa myc-driven cancers cancer conference preclinical pre-clinical

---

ORIC Pharmaceuticals Announces Multiple Data Presentations at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 23:00) - globenewswire.com
ORIC | $9.14 -3.89% 98K |

Health Technology

| -53.32% | O: -0.19% H: 1.49% C: -2.73%
presentation molecular cancer conference

---

Baylor College of Medicine to Present eFFECTOR Therapeutics-Supported Research at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 23:00) - globenewswire.com
EFTR | $1.72 -3.37% 44K |

| -85.84% | O: 0.0% H: 1.85% C: -6.41%
molecular cancer research conference

---

Merus Announces Poster Presentations on Zenocutuzumab and MCLA-158 at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 23:00) - globenewswire.com
MRUS | $40.48 0.03% 180K |

Health Technology

| 86.59% | O: -0.05% H: 1.14% C: 0.05%
presentation molecular cancer conference

---

Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-1535, BRAF, and FGFR Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 23:00) - globenewswire.com
BDTX A | $5.395 1.79% 130K |

Health Technology

| -36.41% | O: 0.24% H: 0.24% C: 0.0%
pre-clinical molecular cancer conference preclinical

---

Kronos Bio to Present Preclinical Data for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers, in Poster Presentation at AACR-NCI-EORTC 2021
Published: 2021-09-30 (Crawled : 23:00) - globenewswire.com
KRON | $1.03 6.8K |

Health Technology

| -95.04% | O: -0.24% H: 3.2% C: 1.29%
presentation cancer preclinical pre-clinical

---

Olema Oncology Announces Trials in Progress Poster on OP-1250 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 23:00) - globenewswire.com
OLMA | $9.84 -0.61% 230K |

Health Technology

| -61.14% | O: 1.6% H: 4.57% C: 3.93%
molecular cancer trials trial conference

---

Mersana Therapeutics to Announce Target and Present New Preclinical Data for XMT-2056 at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 19:00) - biospace.com/
MRSN | $3.285 -1.65% 360K |

Health Technology

| -62.27% | O: 1.18% H: 1.38% C: -0.11%
molecular cancer conference preclinical pre-clinical

---

Revolution Medicines to Present New Preclinical Data from RAS(ON) Inhibitor Programs at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Published: 2021-09-30 (Crawled : 12:00) - globenewswire.com
RVMD S | $35.0 -2.32% 190K |

Health Technology

| 33.02% | O: 0.65% H: 8.56% C: -1.26%
molecular cancer conference preclinical pre-clinical

---

Lands’ End Honors Breast Cancer Awareness Month with Every Step of The Way Initiative
Published: 2021-09-30 (Crawled : 11:00) - globenewswire.com
LE | $12.82 -0.62% 25K |

Retail Trade

| -48.25% | O: -0.6% H: 0.0% C: -4.54%
cancer breast cancer

---

Gainers vs Losers

79%

21%

Top 10 Gainers

AGBA | News | $1.22 205.0% 86M |

Finance

EGOX | $0.0606 68.33% 250M |

NVFY | $3.45 63.51% 20M |

Consumer Durables

CHRO | $1.66 35.51% 70K |

n/a

INDO | $5.43 33.09% 10M |

Energy Minerals

ZCMD | $1.86 28.28% 29M |

Commercial Services

PAPL | $2.07 26.22% 550K |

RWOD | $10.08 26.05% 5.6M |

n/a

HUSA 4 | $2.07 23.95% 2.1M |

Energy Minerals

SRFM 4 | $0.6 21.29% 850K |

n/a

---

Your saved searches

---